Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.329 | The effects of theory-guided multimodal educational (TIME) programme on the faecal occult blood test (FOBT) uptake rates among adults at average-risk of colorectal cancer: A randomized controlled trial | Ms. KWAN Siu Kuen |
| 2025.310 | Systemic absorption of oral vancomycin: prevalence, risk factors, and clinical implications |
Prof. SZETO Cheuk Chun Cheuk Chun Szeto |
| 2025.315 | The Chinese University of Hong Kong Myasthenia Gravis Registry (CUHKMGR) | Dr. CHOI Joseph Chun Ho |
| 2025.311 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.305 | Retrospective Review on the Management of Diabetic Ketoacidosis in the Intensive Care Unit | Dr. HO Lap Tin |
| 2025.323 | Pilot Study on Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer | Prof. TEOH Jeremy Yuen Chun |
| 2025.309 | A portable “sample to answer” microfluidic system for rapid detection of bacterial pathogens using nucleic acid analysis | Prof. LING Lowell |
| 2025.314 | Psychological Distress and its Predictive Factors among Caregiver of Sick Children | Dr. HO Long Kwan |
| 2025.317 | Effectiveness of a Mindfulness-Oriented Respiratory Distress Symptom Intervention for Patients with Lung Cancer and Its Association with Brain Activity Changes | Dr. LOONG Herbert Ho Fung |
| 2025.343 | Development for AI-Powered Retrograde Intrarenal Surgery | Prof. NG Chi Fai |
| 2025.308 | A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in combination with Durvalumab, Carboplatin and Etoposide versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312) | Dr. LOONG Herbert Ho Fung |
| 2025.307 | ASKHER2-China: Perceptions, attitudes, and behaviors towards the risk of disease recurrence among women with early-stage HER2+ breast cancer in mainland China and Hong Kong | Prof. YEO Winnie |
| 2025.328 | Effect of A Remote Counselling Programme on Screening Uptake in First-Degree Relatives of Colorectal Cancer Patients: A Randomised Controlled Trial |
Ms. DONG Bei 董贝 |
| 2025.306 | A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2025.327 | Effectiveness of mHealth-based survivorship programme on health-related quality of life among Vietnamese colorectal cancer survivors: A randomised controlled trial | Ms. DO Pham Nhat Vi |
| 2025.318 | A Phase III, randomised, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronchiectasis (The AIRTIVITY™ Study) | Prof. HUI David Shu Cheong |
| 2025.347 | Impact of intrinsic capacity on the patient-reported and clinical outcomes of geriatric patients | Dr. LEE Jenny Shun Wah |
| 2025.325 | Enhancing First-Attempt Success in Peripheral Venous Catheterization: A Randomized Pilot Study on Infrared Vein Finder Implementation for Phlebotomy Teams in Integrated Ambulatory Care Centre, Hong Kong | Ms. TANG Vivien Wai Man |
| 2025.362 | Phase I-II study of JS207 a bispecific antibody against PD1-VEGF in the treatment of recurrent/metastatic nasopharyngeal carcinoma | Prof. MA Brigette Buig Yue |
| 2025.354 | Evaluation of responses generated by ChatGPT and DeepSeek to drug information questions in hospital setting of Hong Kong | Prof. YOU Joyce Hoi Sze |
| 2025.326 | Development of Zinc Transporter ZIP10-Based Targeted Antibody-Drug Conjugates and Mechanism of Anti-Gastric Cancer |
Dr. CHEN Bonan 陳博南 |
| 2025.357 | Reconstruction and application of interactive virtual environments with real-time navigation for training, planning and rehearsal of transcanal endoscopic ear surgery | Dr. CHANG Wai Tsz |
| 2025.341 | Establishment of a Novel Non-Invasive Biomarker Panel in Peripheral Blood Mononuclear Cells for Predicting Immunotherapy Response in Hepatocellular Carcinoma | Prof. LONG Xiaohang |
| 2025.301 | Multicentre retrospective comparative study of early-onset colorectal cancer (EOCRC): Analysis of clinicopathological, familial and prognostic differences according to the geographical location | Dr. LUI Rashid N.S. |
| 2025.366 | A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of VRN110755 in Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) | Dr. LI Molly Siu Ching |
| 2025.302 | A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has Progressed on Prior Osimertinib Treatment (TROPION-Lung15) | Dr. LI Molly Siu Ching |
| 2025.312 | The impact of contemporary neoadjuvant and adjuvant chemotherapy treatment regimens on recurrence and survival in resectable, borderline resectable, locally advanced and metastatic adenocarcinoma arising from IPMN and internal validation of 2023 KYOTO Guidelines: ADENO-IPMN 2 study | Dr. LUI Rashid N.S. |
| 2025.299 | Multimodality biopsychosocial evaluation and non-pharmacological interventions for cognitive function decline in patients with treatment-resistant schizophrenia-spectrum disorders | Dr. WONG Yip Chau |
| 2025.282 | Investigating the Abnormal Neuromotor Development of Scoliosis from Childhood to Adulthood |
Prof. CHEUNG Vincent Chi Kwan Kelvin Lau |
| 2025.281 | A personalized closed-loop neurofeedback training protocol for emotion regulation in adolescents with major depressive disorder |
Dr. WANG Yang Yang WANG |
| 2025.297 | Neurobiological Studies on Entrepreneurs, Investors/Managers, and Scientists | Prof. AU Kevin |
| 2025.271 | A schedule of work to evaluate the effects of ingestion of various combinations of amino acids on glucose metabolism in healthy individuals and people with impaired glucose tolerance | Prof. CHAN Juliana C.N. |
| 2025.284 | A Retrospective Analysis of Risk Factors, Treatments and Outcomes of Cancer-associated Venous Thromboembolism in Chinese Patients | Dr. WONG Raymond Siu Ming |
| 2025.285 | A Deep Learning System for Predicting Myopia Risk and Atropine Treatment Efficacy | Dr. ZHANG Yuzhou |
| 2025.266 | Prevalence and risk factors of Accelerated Biological Aging in Critically ill and Postoperative Patients: a multicenter prevalence study | Prof. HO Kwok Ming |
| 2025.267 | A pilot randomised study comparing the clinical efficacy of stopping air leak by talc pleurodesis or autologous blood patch therapy in secondary spontaneous pneumothorax | Prof. CHAN Ken Ka Pang |
| 2025.265 | Real-world experience in the use of radiation and systemic therapy in bladder cancer | Dr. YAN Kelvin |
| 2025.399 | Deep Learning-Driven Analysis of Fish Allergies for Advancing Precision Medicine |
Dr. WU Chia Yi 吳嘉儀 |
| 2025.286 | Diagnostic value of CT brain in elderly patients presented with vertigo at the Emergency Department: A retrospective study in Hong Kong | Miss KWOK Kin Yee |
| 2025.246 | Role of minimally invasive tests in predicting clinically significant portal hypertension in patients with unresectable hepatocellular carcinoma |
Prof. LAI Jimmy Che To Lai Che To |
| 2025.268 | Cardio-neural pacing to modulate AV conduction in persistent AF patients – a feasibility study |
Prof. TAM Tsz Kin 譚子健 |
| 2025.293 | A Retrospective Study on Efficacy of Intermittent and Continuous Intraperitoneal Aminoglycoside in Patients with CAPD Peritonitis | Mr. NGAI Thomas |
| 2025.269 | Prenatal cell-free DNA screening in pregnancies with diverse genetic risk profiles utilizing targeted and whole-exome sequencing |
Prof. CHOY Richard Kwong Wai 蔡光伟 |
| 2025.270 | Clinical Study for HerResolve™ in Detecting the Presence of Endometriosis among Symptomatic Women of ages 18-49 years Considering Laparoscopy | Prof. CHUNG Jacqueline Pui Wah |
| 2025.272 | Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial | Ms. SUN Wai Han |
| 2025.247 | Arresting Enthesiophyte and Erosion Progression in PsA: A 5-Year HR-pQCT Study | Prof. TAM Lai Shan |
| 2025.248 | Investigating the integrated stress response in vascular smooth muscle cells and the implication in aortic aneurysm | Dr. TIAN Xiaoyu |
| 2025.242 | A single arm, multicenter, open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in participants who completed the parent Lp(a)HORIZON trial | Prof. YAN Bryan Ping Yen |
| 2025.244 | AI-Powered Decision-Making Model in Optimizing Belimumab and Telitacicept Treatment for SLE through Genetic and Immune Profiling |
Prof. TAM Lai Shan 譚麗珊 |
| 2025.287 | Enhancing Patient Safety through AI-Based Detection of Nasogastric Tube Positioning in Chest X-Rays | Dr. TSUI Chi Leung |
Page 19 of 285.